An Integrative MuSiCO Algorithm: From the Patient-Specific Transcriptional Profiles to Novel Checkpoints in Disease Pathobiology

5Citations
Citations of this article
4Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Strong efforts are invested in the field of cancer and other multifactorial diseases to evaluate the applicability of gene expression patterns for identification of novel disease-relevant checkpoints and nomination of promising biomarkers for disease and/or targets. Deciphering the disease complexity demands the implementation of a holistic approach, which covers the levels of the biological hierarchy from molecules to functional gene network(s) and biological pathways and further to disease (patho)mechanisms and clinical relevance. In this chapter we describe the systems biology-based integrative algorithm, named by us as MuSiCO/fromMultigeneSignature to Patient-OrientatedClinicalOutcome, and discuss its applicability for translational research. This innovative approach is based on the implementation of consecutive analytical modules integrating advanced gene expression profiling of clinical patient specimens, prognostic/predictive modeling, digital pathology, and systems biology. It consolidates in-depth expertise from diverse scientific and medical disciplines and hereby bridges systems biology and systems medicine to maximize the benefit of the patient.

Cite

CITATION STYLE

APA

Meshcheryakova, A., Zimmermann, P., Ecker, R., Mungenast, F., Heinze, G., & Mechtcheriakova, D. (2018). An Integrative MuSiCO Algorithm: From the Patient-Specific Transcriptional Profiles to Novel Checkpoints in Disease Pathobiology. In RNA Technologies (pp. 351–372). Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/978-3-319-92967-5_18

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free